Application of neuroprotectors in severe brain injuries

Blood concentration of protein S100 was been decreased with choline-liked neuroprotectors citicoline and choline alfoscerate in clinical trial 52 patients in early day after stroke. Concentration of neuron-specific enolase was been decreased with three month mildronat therapy in blood of 16 patients...

Full description

Bibliographic Details
Main Authors: O. Ye. Vaizova, N. A. Zautner, V. M. Alifirova, D. V. Kolmakov, Ye. L. Golovina, A. S. Molodykh
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2011-10-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/1461
_version_ 1797873048084283392
author O. Ye. Vaizova
N. A. Zautner
V. M. Alifirova
D. V. Kolmakov
Ye. L. Golovina
A. S. Molodykh
author_facet O. Ye. Vaizova
N. A. Zautner
V. M. Alifirova
D. V. Kolmakov
Ye. L. Golovina
A. S. Molodykh
author_sort O. Ye. Vaizova
collection DOAJ
description Blood concentration of protein S100 was been decreased with choline-liked neuroprotectors citicoline and choline alfoscerate in clinical trial 52 patients in early day after stroke. Concentration of neuron-specific enolase was been decreased with three month mildronat therapy in blood of 16 patients with traumatic brain injury. Neuroprotective therapy has stabilization of blood-brain barrier as result.
first_indexed 2024-04-10T01:09:59Z
format Article
id doaj.art-95393b9ea0db41aba95d0c92aef107bc
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:09:59Z
publishDate 2011-10-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-95393b9ea0db41aba95d0c92aef107bc2023-03-13T09:58:15ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842011-10-01105364010.20538/1682-0363-2011-5-36-40968Application of neuroprotectors in severe brain injuriesO. Ye. Vaizova0N. A. Zautner1V. M. Alifirova2D. V. Kolmakov3Ye. L. Golovina4A. S. Molodykh5Сибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетBlood concentration of protein S100 was been decreased with choline-liked neuroprotectors citicoline and choline alfoscerate in clinical trial 52 patients in early day after stroke. Concentration of neuron-specific enolase was been decreased with three month mildronat therapy in blood of 16 patients with traumatic brain injury. Neuroprotective therapy has stabilization of blood-brain barrier as result.https://bulletin.ssmu.ru/jour/article/view/1461ишемический инсультчерепно-мозговая травмабелок s100нейронспецифическая енолазацитиколинхолина альфосцератмилдронат
spellingShingle O. Ye. Vaizova
N. A. Zautner
V. M. Alifirova
D. V. Kolmakov
Ye. L. Golovina
A. S. Molodykh
Application of neuroprotectors in severe brain injuries
Бюллетень сибирской медицины
ишемический инсульт
черепно-мозговая травма
белок s100
нейронспецифическая енолаза
цитиколин
холина альфосцерат
милдронат
title Application of neuroprotectors in severe brain injuries
title_full Application of neuroprotectors in severe brain injuries
title_fullStr Application of neuroprotectors in severe brain injuries
title_full_unstemmed Application of neuroprotectors in severe brain injuries
title_short Application of neuroprotectors in severe brain injuries
title_sort application of neuroprotectors in severe brain injuries
topic ишемический инсульт
черепно-мозговая травма
белок s100
нейронспецифическая енолаза
цитиколин
холина альфосцерат
милдронат
url https://bulletin.ssmu.ru/jour/article/view/1461
work_keys_str_mv AT oyevaizova applicationofneuroprotectorsinseverebraininjuries
AT nazautner applicationofneuroprotectorsinseverebraininjuries
AT vmalifirova applicationofneuroprotectorsinseverebraininjuries
AT dvkolmakov applicationofneuroprotectorsinseverebraininjuries
AT yelgolovina applicationofneuroprotectorsinseverebraininjuries
AT asmolodykh applicationofneuroprotectorsinseverebraininjuries